Drug Discovery & Development | Q&As & Interviews

Addressing Immunotherapy Resistance Through PVRIG And TIGIT Blockade

In this interview, Eran Ophir discusses Compugen's exciting approach to immune checkpoint inhibitors for the treatment of cancer and what makes them stand out from the crowd.
https://www.youtube.com/watch?v=M6kw7ppYVTo